Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Bipolar depression and diagnostic pitfalls

Psychiatry · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Bipolar depression with acute danger

Current suicidal intent, severe self-neglect, psychotic depression, catatonia, inability to eat or drink, mixed activation or postpartum deterioration needs urgent physical and psychiatric intervention.

Action: Assess ABCDE and immediate medical consequences, restrict relevant means, arrange proportionate observation and obtain same-day specialist review. Clarify mixed or psychotic features, decision-specific capacity, dependants and the least restrictive safe care setting while treatment is planned.

Synopsis

Recognise depression within a bipolar course, retrieve lifetime evidence of activation before choosing treatment, exclude important medical and substance mimics, and manage current severity without waiting for perfect retrospective certainty.

  • Bipolar depression can look identical to unipolar depression in cross-section; diagnosis depends on the lifetime course, not a special depressive symptom checklist.
  • Ask every depressed adult about previous overactivity, disinhibition, elevated or irritable mood, reduced sleep need, increased speech, projects, spending and treatment-related activation.
  • NICE advises considering specialist assessment when previous overactivity or disinhibition lasted four days or more and urgent referral for suspected mania, severe depression or danger.
  • Retrieve records and agreed collateral because past hypomania may have felt productive, occurred years earlier or been forgotten during the present low mood.
  • Assess current suicide risk, psychosis, catatonia, mixed activation, self-care, dependants, substances and access to medication before focusing on diagnostic terminology.
  • Check thyroid, anaemia, sleep, neurological, reproductive, medicine and substance explanations selectively from the history and examination; routine tests do not diagnose bipolar disorder.
  • For moderate or severe bipolar depression without current bipolar medication, NICE offers fluoxetine with olanzapine or quetiapine alone, with olanzapine alone or lamotrigine as preference-sensitive alternatives.
  • If lithium is already prescribed, check the plasma concentration and optimise an inadequate level before adding the NICE-recommended depressive treatment selected with the patient.
  • Monitor for emerging hypomania, worsening depression, adverse effects and suicide risk, and limit quantities where overdose toxicity is a material concern.

Key red flags

Suicidal preparation, access to lethal means, recent self-harm, severe hopelessness or an agitated mixed state requires immediate individual formulation and intervention.

Reduced sleep need, racing thoughts, agitation and impulsivity during apparent depression may indicate mixed features and greater capability for harmful action.

Delusions of guilt, poverty, bodily non-existence or deserved punishment, accusatory voices or catatonic signs indicate severe bipolar depression requiring urgent specialist care.

Confusion, fluctuating attention, focal neurology, fever, new seizure or abrupt late-life onset suggests delirium or neurological disease rather than an uncomplicated mood episode.

Depression, insomnia, irritability or psychosis arising during pregnancy or after birth requires rapid perinatal assessment and medication-risk review.

Investigation priorities

01
Lifetime mood chronologyFirst step

Map depressive, elevated, irritable and mixed periods, inter-episode recovery, duration, triggers and functional consequences.

Management branches

Depression with bipolar cluesRetrieve course before routine prescribing

Current depression is accompanied by previous activation, disinhibition or reduced sleep need.

  1. Establish current severity, suicide risk, psychosis and mixed features and provide urgent care first when danger or severe illness is present.
  2. Build a lifetime timeline using behavioural examples, records and consented collateral and review substances, medicines and medical explanations.
  3. Seek specialist bipolar assessment and agree interim safety, sleep and treatment plans that include monitoring for activation and clear escalation routes.

Key medicines

Quetiapine immediate-releaseFor bipolar depression, take 50 mg at bedtime on day one, 100 mg on day two, 200 mg on day three and 300 mg on day four; the recommended daily dose is 300 mg.Check metabolic and cardiovascular baseline, sedation, orthostasis and falls risk; monitor weight, glucose, lipids and movement effects and review interactions, pregnancy and driving safety.
LamotrigineWhen not taking valproate or enzyme-inducing medicines, use 25 mg once daily for weeks one and two, 50 mg daily for weeks three and four, then increase gradually toward 200 mg daily according to the product schedule.Dosing changes substantially with valproate or enzyme inducers; stop and assess any rash urgently because serious skin reactions are associated with rapid titration and early treatment.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG185 bipolar disorder recommendationsPrimary-care recognition, specialist assessment and treatment of bipolar depression.
  • Quetiapine UK summary of product characteristicsLicensed bipolar-depression titration, recommended dose, cautions and adverse effects.
  • Lamictal tablets summary of product characteristicsInteraction-dependent lamotrigine titration and serious skin-reaction precautions.
  • NHS bipolar disorder treatmentPatient-facing overview of medicines, psychological care and self-management.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom